Roger Michael Gendreau

CIK: 0001826131

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

DWTX

Dogwood Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

DWTX
Dogwood Therapeutics, Inc.
Mar 5, 2026
Award(A)
Stock Option (right to buy)
Direct
82.5K shares-
DWTX
Dogwood Therapeutics, Inc.
Dec 4, 2025
Award(A)
Stock Option (right to buy)
Direct
150K shares-
DWTX
Dogwood Therapeutics, Inc.
Jun 27, 2025
Award(A)
Stock Option (right to buy)
Direct
12.1K shares-

		Type	Shares	Price		Ownership
Mar 5, 2026	DWTX Dogwood Therapeutics, Inc.	Award(A) Stock Option (right to buy)	82,500	-	-	Direct
Dec 4, 2025	DWTX Dogwood Therapeutics, Inc.	Award(A) Stock Option (right to buy)	150,000	-	-	Direct
Jun 27, 2025	DWTX Dogwood Therapeutics, Inc.	Award(A) Stock Option (right to buy)	12,075	-	-	Direct

1-3 of 3 transactions

About Gendreau Roger Michael

Gendreau Roger Michael (SEC CIK 0001826131) files insider reports with the SEC as CHIEF MEDICAL OFFICER of Dogwood Therapeutics, Inc. (DWTX).

Signal8 holds 3 ownership filings by Gendreau Roger Michael, all Form 4s, filed between Jul 1, 2025 and Mar 6, 2026. Those filings report 3 transactions, from Jun 27, 2025 to Mar 5, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Gendreau Roger Michael's filings is in ALPHARETTA, GA.

Recent filings by Gendreau Roger Michael

Mar 5, 2026: Grant or award of DWTX derivative securities (Form 4, code A).
Dec 4, 2025: Grant or award of DWTX derivative securities (Form 4, code A).
Jun 27, 2025: Grant or award of DWTX derivative securities (Form 4, code A).

Other insiders filing for Dogwood Therapeutics, Inc. (DWTX)

Sealbond Ltd, Director
De La Rosa Abel, Director
Thomas John C, Director
Whitley Richard James, Director
Keefer David R, Director
Grosswald Ralph, SVP OF OPERATIONS

How to read Form 4 transaction codes